MedPath

MED DISCOVERY SA

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

MDPK67b in Patients With Prostate Cancer

Phase 1
Recruiting
Conditions
Prostate Cancer
Interventions
Drug: MDPK67b
First Posted Date
2022-10-14
Last Posted Date
2023-11-07
Lead Sponsor
Med Discovery SA
Target Recruit Count
15
Registration Number
NCT05580107
Locations
🇨🇭

Klinik für Urologie, UniversitätSpital Zürich (USZ), Zürich, Switzerland

PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers

Phase 1
Completed
Conditions
Prostatic Neoplasms
Interventions
Drug: MDPK67b
Drug: Placebo
First Posted Date
2021-04-09
Last Posted Date
2021-04-09
Lead Sponsor
Med Discovery SA
Target Recruit Count
8
Registration Number
NCT04839120
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois (CHUV) - Division of Clinical Pharmacology, Lausanne, Switzerland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.